Johnson & Johnson (JNJ) EPS (Basic) (2009 - 2026)

Johnson & Johnson has disclosed EPS (Basic) across 18 years of filings, most recently posting $2.3 for Q2 2026.

• In Q2 2026, EPS (Basic) changed 0.1% year-over-year to $2.3; the TTM figure through Jun 2026 stood at $8.74 (down 7.21% YoY), while the FY2025 annual figure was $11.13, up 90.55% from the prior year.
• EPS (Basic) came in at $2.3 for Q2 2026 at Johnson & Johnson, up from $2.17 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $10.32 in Q4 2023 to a low of -$0.03 in Q2 2023.
• Average EPS (Basic) over 5 years is $2.32, with a median of $1.94 recorded in 2022.
• Year-over-year, EPS (Basic) tumbled 101.35% in 2023 and surged 5278.94% in 2024.
• Over 5 years, EPS (Basic) stood at $1.7 in 2022, then retreated by 5.79% to $1.6 in 2023, then slipped by 10.82% to $1.43 in 2024, then jumped by 49.1% to $2.13 in 2025, then climbed by 8.17% to $2.3 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $2.3 in Q2 2026, $2.17 in Q1 2026, and $2.13 in Q4 2025.